Загрузка...
PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
The non-receptor tyrosine kinase, PTK6/BRK, is highly expressed in multiple tumor types, including prostate, ovarian, and breast cancers, and regulates oncogenic phenotypes such as proliferation, migration, and survival. PTK6 inhibition also overcomes targeted therapy resistance of HER2+ breast canc...
Сохранить в:
| Опубликовано в: : | NPJ Breast Cancer |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5694002/ https://ncbi.nlm.nih.gov/pubmed/29167821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-017-0047-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|